A detailed history of Core Cap Advisors, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Core Cap Advisors, LLC holds 550 shares of GKOS stock, worth $79,200. This represents 0.0% of its overall portfolio holdings.

Number of Shares
550
Holding current value
$79,200
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$113.62 - $135.39 $62,491 - $74,464
550 New
550 $71,000
Q1 2024

Aug 08, 2024

BUY
$76.4 - $96.33 $15,280 - $19,266
200 New
200 $18,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.85B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.